Chlortalidone

CLINICAL USE

Thiazide-like diuretic:Hypertension Ascites Oedema Diabetes insipidus Mild to moderate heart failure

DOSE IN NORMAL RENAL FUNCTION

Hypertension: 25–50 mg daily Oedema: 50 mg daily initially Diabetes insipidus: 100 mg every 12 hours initially, reducing to 50 mg daily where possibleHeart failure: 25–50 mg daily increasing to 100–200 mg daily

PHARMACOKINETICS

  • Molecular weight                           :338.8
  • %Protein binding                           :76
  • %Excreted unchanged in urine     : 50
  • Volume of distribution (L/kg)       :3.9
  • half-life – normal/ESRD (hrs)      :40–60/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

    30–50 Dose as in normal renal function <30 Avoid. See ‘Other Information’

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Avoid
  • HD                     :Not dialysed. Avoid
  • HDF/high flux   :Unknown dialysability. Avoid
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsAnalgesics: increased risk of nephrotoxicity with NSAIDs; antagonism of diuretic effectAnti-arrhythmics: hypokalaemia leads to increased cardiac toxicity; effects of lidocaine and mexiletine antagonisedAntibacterials: avoid administration with lymecyclineAntidepressants: increased risk of hypokalaemia with reboxetine; enhanced hypotensive effect with MAOIs; increased risk of postural hypotension with tricyclicsAnti-epileptics: increased risk of hyponatraemia with carbamazepineAntifungals: increased risk of hypokalaemia with amphotericinAntihypertensives: enhanced hypotensive effect; increased risk of first dose hypotension with post-synaptic alpha-blockers like prazosin; hypokalaemia increases risk of ventricular arrhythmias with sotalolAntipsychotics: hypokalaemia increases risk of ventricular arrhythmias with amisulpiride or sertindole; enhanced hypotensive effect with phenothiazines; hypokalaemia increases risk of ventricular arrhythmias with pimozide – avoid concomitant use. Atomoxetine: hypokalaemia increases risk of ventricular arrhythmiasCardiac glycosides: increased toxicity if hypokalaemia occursCiclosporin: increased risk of nephrotoxicity and hypomagnesaemiaLithium excretion reduced, increased toxicity

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    A single dose at breakfast time is preferable

    OTHER INFORMATION

    Can precipitate diabetes mellitus and gout, and cause severe electrolyte disturbances and an increase in serum lipidsThiazide diuretics are unlikely to be of use once GFR<30 mL/min

  • Related News